Skip to main content
SpringerLink
Log in
Book cover

Quasispecies: Concept and Implications for Virology pp 171–192Cite as

Evolutionary Dynamics of HIV-1 and the Control of AIDS

  • Chapter

Part of the book series: Current Topics in Microbiology and Immunology ((CT MICROBIOLOGY,volume 299))

Abstract

Human immunodeficiency viruses (HIV) have exhibited an extraordinary capacity for genetic change, exploring new evolutionary space after each transmission to a new host. This presents a great challenge to the prevention and management of HIV-1 infection. At the same time, the relentless diversification of HIV-1, developing as it does under the constraints imposed by the human immune system and other selective forces, contains within it information useful for understanding HIV epidemiology and pathogenesis. Comparing the sheer mutational potential of HIV with actual data representing viral lineages that can survive selection suggests that HIV does not have unlimited capacity for change. Rather, clinical and bioinformatic data suggest that, even in the most diverse gene of the most highly variable organism, natural selection places severe limits on the portion of amino acid sequence space that ensures viability. This suggests some optimism for those attempting to identify sets of antigens that can generate effective humoral and cellular immune responses against HIV.

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   169.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   219.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Achaz G, Palmer S, Kearney M, Maldarelli F, Mellors JW, Coffin JM, Wakeley J (2004) A robust measure of HIV-1 population turnover within chronically infected individuals. Mol Biol Evol 21:1902–1912

    CAS  PubMed  Google Scholar 

  • Aldrovandi GM (1999) Natural history of pediatric HIV disease. Lippincott Williams and Wilkins, Philadelphia

    Google Scholar 

  • Allen TM, Altfeld M, Yu XG, O’Sullivan KM, Lichterfeld M, Le Gall S, John M, Mothe BR, Lee PK, Kalife ET, Cohen DE, Freedberg KA, Strick DA, Johnston MN, Sette A, Rosenberg ES, Mallal SA, Goulder PJ, Brander C, Walker BD (2004) Selection, transmission, and reversion of an antigen-processing cytotoxic T-lymphocyte escape mutation in human immunodeficiency virus type 1 infection. J Virol 78:7069–7078

    CAS  PubMed  Google Scholar 

  • Altfeld M, Walker BD (2001) Less is more? STI in acute and chronic HIV-1 infection. Nat Med 7:881–884

    Article  CAS  PubMed  Google Scholar 

  • Altfeld M, Allen TM, Yu XG, Johnston MN, Agrawal D, Korber BT, Montefiori DC, O’Connor DH, Davis BT, Lee PK, Maier EL, Harlow J, Goulder PJ, Brander C, Rosenberg ES, Walker BD (2002) HIV-1 superinfection despite broad CD8+ T-cell responses containing replication of the primary virus. Nature 420:434–439

    Article  CAS  PubMed  Google Scholar 

  • Arts EJ, Quinones-Mateu ME (2003) Sorting out the complexities of HIV-1 fitness. Aids 17:780–781

    Article  PubMed  Google Scholar 

  • Bickel PJ, Cosman PC, Olshen RA, Spector PC, Rodrigo AR, Mullins JI (1996) Covariability of V3 loop amino acids. AIDS Res Human Retrovir 12:1401–1411

    CAS  Google Scholar 

  • Bienzle D, MacDonald KS, Smaill FM, Kovacs C, Baqi M, Courssaris B, Luscher MA, Walmsley SL, Rosenthal KL (2000) Factors contributing to the lack of human immunodeficiency virus type 1 (HIV-1) transmission in HIV-1-discordant partners. J Infect Dis 182:123–132

    Article  CAS  PubMed  Google Scholar 

  • Birk M, Svedhem V, Sonnerborg A (2001) Kinetics of HIV-1 RNA and resistance-associated mutations after cessation of antiretroviral combination therapy. Aids 15:1359–1368

    Article  CAS  PubMed  Google Scholar 

  • Björndal A, Deng H, Jansson M, Fiore JR, Colognesi C, Karlsson A, Albert J, Scarlatti G, Littman DR, Fenyö EM (1997) Coreceptor usage of primary human immunodeficiency virus type 1 isolates varies according to biological phenotype. J Virol 71:7478–7487

    PubMed  Google Scholar 

  • Brenner BG, Routy JP, Petrella M, Moisi D, Oliveira M, Detorio M, Spira B, Essabag V, Conway B, Lalonde R, Sekaly RP, Wainberg MA (2002) Persistence and fitness of multidrug-resistant human immunodeficiency virus type 1 acquired in primary infection. J Virol 76:1753–1761

    Article  CAS  PubMed  Google Scholar 

  • Bretscher MT, Althaus CL, Muller V, Bonhoeffer S (2004) Recombination in HIV and the evolution of drug resistance: for better or for worse? Bioessays 26:180–188

    Article  CAS  PubMed  Google Scholar 

  • Brumme ZL, Dong WWY, Yip B, Wynhoven B, Hoffman NG, Swanstrom R, Jensen MA, Mullins JI, Hogg RS, Montaner JSG, Harrigan PR (2004) Clinical and immunological impact of HIV envelope V3 sequence variation after starting initial triple antiretroviral therapy. Aids 18:F1–F9

    CAS  PubMed  Google Scholar 

  • Casartelli N, Di Matteo G, Potesta M, Rossi P, Doria M (2003) CD4 and major histocompatibility complex class I downregulation by the human immunodeficiency virus type 1 nef protein in pediatric AIDS progression. J Virol 77:11536–11545

    Article  CAS  PubMed  Google Scholar 

  • Chen R, Quinones-Mateu ME, Mansky LM (2004) Drug resistance, virus fitness and HIV-1 mutagenesis. Curr Pharm Des 10:4065–4070

    CAS  PubMed  Google Scholar 

  • Chen R, Quinones-Mateu ME, Mansky LM (2005) HIV-1mutagenesis during antiretroviral therapy: implications for successful drug treatment. Front Biosci 10:743–750

    CAS  PubMed  Google Scholar 

  • Chun TW, Stuyver L, Mizell SB, Ehler LA, Mican JA, Baseler M, Lloyd AL, Nowak MA, Fauci AS (1997) Presence of an inducible HIV-1 latent reservoir during highly active antiretroviral therapy. Proc Natl Acad Sci U S A 94:13193–13197

    Article  CAS  PubMed  Google Scholar 

  • Chun TW, Davey RT Jr, Ostrowski M, Shawn Justement J, Engel D, Mullins JI, Fauci AS (2000) Relationship between pre-existing viral reservoirs and the re-emergence of plasma viremia after discontinuation of highly active anti-retroviral therapy. Nat Med 6:757–761

    Article  CAS  PubMed  Google Scholar 

  • Connor RI, Sheridan KE, Ceradini D, Choe S, Landau NR (1997) Change in coreceptor use correlates with disease progression in HIV-1-infected individuals. J Exp Med 185:621–628

    Article  CAS  PubMed  Google Scholar 

  • Cooper DA, Imrie AA, Penney R (1987) Antibody response to human immunodeficiency virus after primary infection. J Infect Dis 155:1113–1118

    CAS  PubMed  Google Scholar 

  • Daar ES, Moudgil T, Meyer RD, Ho DD (1991) Transient high levels of viremia in patients with primary HIV-1 infection. N Engl J Med 324:961–964

    CAS  PubMed  Google Scholar 

  • De Jong JJ, Goudsmit J, Keulen W, Klaver B, Krone W, Tersmette M, de Ronde A (1992) Human immunodeficiency virus type 1 clones chimeric for the envelope V3 domain differ in syncytium formation and replication capacity. J Virol 66:757–765

    PubMed  Google Scholar 

  • Deeks SG, Barbour JD, Martin JN, Swanson MS, Grant RM (2000) Sustained CD4+ T cell response after virologic failure of protease inhibitor-based regimens in patients with human immunodeficiency virus infection. J Infect Dis 181:946–953

    Article  CAS  PubMed  Google Scholar 

  • Deeks SG, Wrin T, Liegler T, Hoh R, Hayden M, Barbour JD, Hellmann NS, Petropoulos CJ, McCune JM, Hellerstein MK, Grant RM (2001) Virologic and immunologic consequences of discontinuing combination antiretroviral-drug therapy in HIV-infected patients with detectable viremia. N Engl J Med 344:472–480

    Article  CAS  PubMed  Google Scholar 

  • Deeks SG, Grant RM, Wrin T, Paxinos EE, Liegler T, Hoh R, Martin JN, Petropoulos CJ (2003) Persistence of drug-resistant HIV-1 after a structured treatment interruption and its impact on treatment response. Aids 17:361–370

    Article  CAS  PubMed  Google Scholar 

  • Delwart EL, Sheppard HW, Walker BD, Goudsmit J, Mullins JI (1994) Human immunodeficiency virus type 1 evolution in vivo tracked by DNA heteroduplex mobility assays. J Virol 68:6672–6683

    CAS  PubMed  Google Scholar 

  • Derdeyn CA, Decker JM, Bibollet-Ruche F, Mokili JL, Muldoon M, Denham SA, Heil ML, Kasolo F, Musonda R, Hahn BH, Shaw GM, Korber BT, Allen S, Hunter E (2004) Envelope-constrained neutralization-sensitive HIV-1 after heterosexual transmission. Science 303:2019–2022

    Article  CAS  PubMed  Google Scholar 

  • Desrosiers RC (2004) Prospects for an AIDS vaccine. Nat Med 10:221–223

    Article  CAS  PubMed  Google Scholar 

  • Di Mascio M, Markowitz M, Louie M, Hurley A, Hogan C, Simon V, Follmann D, Ho DD, Perelson AS (2004) Dynamics of intermittent viremia during highly active antiretroviral therapy in patients who initiate therapy during chronic versus acute and early human immunodeficiency virus type 1 infection. J Virol 78:10566–10573

    PubMed  Google Scholar 

  • Domingo E, Menendez-Arias L, Quinones-Mateu ME, Holguin A, Gutierrez-Rivas M, Martinez MA, Quer J, Novella IS, Holland JJ (1997) Viral quasispecies and the problem of vaccine-escape and drug-resistant mutants. Prog Drug Res 48:99–128

    CAS  PubMed  Google Scholar 

  • Dybul M, Chun TW, Yoder C, Hidalgo B, Belson M, Hertogs K, Larder B, Dewar RL, Fox CH, Hallahan CW, Justement JS, Migueles SA, Metcalf JA, Davey RT, Daucher M, Pandya P, Baseler M, Ward DJ, Fauci AS (2001) Short-cycle structured intermittent treatment of chronic HIV infection with highly active antiretroviral therapy: effects on virologic, immunologic, and toxicity parameters. Proc Natl Acad Sci U S A 98:15161–15166

    Article  CAS  PubMed  Google Scholar 

  • Dybul M, Daucher M, Jensen MA, Hallahan CW, Chun TW, Belson M, Hidalgo B, Nickel DC, Yoder C, Metcalf JA, Davey RT, Ehler L, Kress-Rock D, Nies-Kraske E, Liu S, Mullins JI, Fauci AS (2003) Genetic characterization of rebounding human immunodeficiency virus type 1 in plasma during multiple interruptions of highly active antiretroviral therapy. J Virol 77:3229–3237

    Article  CAS  PubMed  Google Scholar 

  • Finzi D, Blankson J, Siliciano JD, Margolick JB, Chadwick K, Pierson T, Smith K, Lisziewicz J, Lori F, Flexner C, Quinn TC, Chaisson RE, Rosenberg E, Walker B, Gange S, Gallant J, Siliciano RF (1999) Latent infection of CD4+ T cells provides a mechanism for lifelong persistence of HIV-1, even in patients on effective combination therapy. Nat Med 5:512–517

    CAS  PubMed  Google Scholar 

  • Fouchier RAM, Groenink M, Kootstra NA, Tersmette M, Huisman HG, Miedema F, Schuitemaker H (1992) Phenotype-associated sequence variation in the third variable domain (V3) of the human immunodeficiency virus type 1 gp120 molecule. J Virol 66:3183–3187

    CAS  PubMed  Google Scholar 

  • Fowke KR, Nagelkerke NJ, Kimani J, Simonsen JN, Anzala AO, Bwayo JJ, MacDonald KS, Ngugi EN, Plummer FA (1996) Resistance to HIV-1 infection among persistently seronegative prostitutes in Nairobi, Kenya. Lancet 348:1347–1351

    Article  CAS  PubMed  Google Scholar 

  • Frenkel LM, Mullins JI (2001) Should patients with drug-resistant HIV-1 continue to receive antiretroviral Therapy? N Engl J Med 344:520–522

    Article  CAS  PubMed  Google Scholar 

  • Frenkel LM, Wang Y, Learn GH, McKernan JL, Ellis GM, Mohan KM, Holte SE, De Vange SM, Pawluk DM, Melvin AJ, Lewis PF, Heath LM, Beck IA, Mahalanabis M, Naugler WE, Tobin NH, Mullins JI (2003) Multiple viral genetic analyses detecting low-level HIV-1 replication during effective HAART. J Virol 77:5721–5730

    Article  CAS  PubMed  Google Scholar 

  • Friedrich TC, Dodds EJ, Yant LJ, Vojnov L, Rudersdorf R, Cullen C, Evans DT, Desrosiers RC, Mothe BR, Sidney J, Sette A, Kunstman K, Wolinsky S, Piatak M, Lifson J, Hughes AL, Wilson N, O’Connor DH, Watkins DI (2004) Reversion of CTL escape-variant immunodeficiency viruses in vivo. Nat Med 10:275–281

    Article  CAS  PubMed  Google Scholar 

  • Goudsmit J, De Ronde A, Ho DD, Perelson AS (1996) Human immunodeficiency virus fitness in vivo: calculations based on a single zidovudine resistance mutation at codon 215 of reverse transcriptase. J Virol 70:5662–5664

    CAS  PubMed  Google Scholar 

  • Grobler J, Gray CM, Rademeyer C, Seoighe C, Ramjee G, Abdool Karim S, Morris L, Williamson C (2004) Incidence of HIV-1 dual infection and its association with increased viral load set point in a cohort of HIV-1 subtype C-infected female sex workers. J Infect Dis 190:1355–1359

    Article  PubMed  Google Scholar 

  • Gunthard HF, Frost SD, Leigh-Brown AJ, Ignacio CC, Kee K, Perelson AS, Spina CA, Havlir DV, Hezareh M, Looney DJ, Richman DD, Wong JK (1999) Evolution of envelope sequences of human immunodeficiency virus type1 in cellular reservoirs in the setting of potent antiviral therapy. J Virol 73:9404–9412

    CAS  PubMed  Google Scholar 

  • Hatano H, Vogel S, Yoder C, Metcalf JA, Dewar R, Davey RT Jr, Polis MA (2000) Pre-HAART HIV burden approximates post-HAART viral levels following interruption of therapy in patients with sustained viral suppression. Aids 14:1357–1363

    CAS  PubMed  Google Scholar 

  • Ho DD (1998) Toward HIV eradication or remission: the tasks ahead. Science 280:1866–1867

    Article  CAS  PubMed  Google Scholar 

  • Ho DD, Sarngadharan MG, Resnick L, Dimarzoveronese F, Rota TR, Hirsch MS (1985) Primary human T-lymphotropic virus type III infection. Ann Intern Med 103:880–883

    CAS  PubMed  Google Scholar 

  • Hoffman NG, Seillier-Moiseiwitsch F, Ahn J, Walker JM, Swanstrom R (2002) Variability in the human immunodeficiency virus type 1 gp120 Env protein linked to phenotype-associated changes in the V3 loop. J Virol 76:3852–3864

    Article  CAS  PubMed  Google Scholar 

  • Huang Y, Paxton WA, Wolinsky SM, Neumann AU, Zhang L, He T, Kang S, Ceradini D, Jin Z, Yazdanbakhsh K, Kunstman K, Erickson D, Dragon E, Landau NR, Phair J, Ho DD, Koup RA (1996) The role of a mutant CCR5 allele in HIV-1 transmission and disease progression [see comments]. Nat Med 2:1240–1243

    Article  CAS  PubMed  Google Scholar 

  • Jain RG, Furfine ES, Pedneault L, White AJ, Lenhard JM (2001) Metabolic complications associated with antiretroviral therapy. Antiviral Res 51:151–177

    Article  CAS  PubMed  Google Scholar 

  • Jensen MA, van’ t Wout AB (2003) Predicting HIV-1 coreceptor usage with sequence analysis. AIDS Rev 5:104–112

    PubMed  Google Scholar 

  • Jensen MA, Li F-S, van’ t Wout AB, Nickle DC, Shriner D, He H, McLaughlin S, Shankarappa R, Margolick JB, Mullins JI (2003) Improved coreceptor usage prediction and genotypic monitoring of R5-to-X4 transition by motif analysis of human immunodeficiency virus type 1 env V3 loop sequences. J Virol 77:13376–13388

    CAS  PubMed  Google Scholar 

  • Jost S, Bernard MC, Kaiser L, Yerly S, Hirschel B, Samri A, Autran B, Goh LE, Perrin L (2002) A patient with HIV-1 superinfection. N Engl J Med 347:731–736

    Article  PubMed  Google Scholar 

  • Karlsson I, Antonsson L, Shi Y, Karlsson A, Albert J, Leitner T, Olde B, Owman C, Fenyo EM (2003) HIV biological variability unveiled: frequent isolations and chimeric receptors reveal unprecedented variation of coreceptor use. Aids 17:2561–2569

    PubMed  Google Scholar 

  • Kaufmann DE, Lichterfeld M, Altfeld M, Addo MM, Johnston MN, Lee PK, Wagner BS, Kalife ET, Strick D, Rosenberg ES, Walker BD (2004) Limited durability of viral control following treated acute HIV infection. Plos Med 1:e36

    Article  PubMed  Google Scholar 

  • Kaul R, Rowland-Jones SL, Kimani J, Dong T, Yang HB, Kiama P, Rostron T, Njagi E, Bwayo JJ, MacDonald KS, McMichael AJ, Plummer FA (2001) Late seroconversion in HIV-resistant Nairobi prostitutes despite pre-existing HIV-specific CD8+ responses. J Clin Invest 107:341–349

    CAS  PubMed  Google Scholar 

  • Kiepiela P, Leslie AJ, Honeyborne I, Ramduth D, Thobakgale C, Chetty S, Rathnavalu P, Moore C, Pfafferott KJ, Hilton L, Zimbwa P, Moore S, Allen T, Brander C, Addo MM, Altfeld M, James I, Mallal S, Bunce M, Barber LD, Szinger J, Day C, Klenerman P, Mullins J, Korber B, Coovadia HM, Walker BD, Goulder PJ (2004) Dominant influence of HLA-B in mediating the potential co-evolution of HIV and HLA. Nature 432:769–775

    Article  CAS  PubMed  Google Scholar 

  • Kijak GH, Simon V, Balfe P, Vanderhoeven J, Pampuro SE, Zala C, Ochoa C, Cahn P, Markowitz M, Salomon H (2002) Origin of human immunodeficiency virus type 1 quasispecies emerging after antiretroviral treatment interruption in patients with therapeutic failure. J Virol 76:7000–7009

    Article  CAS  PubMed  Google Scholar 

  • Koot M, Keet I, Vos A, deGoede R, Roos M, Coutinho R, Miedema F, Schellekens P, Tersmette M (1993) Prognostic value of HIV-1 syncytium-inducing phenotype for rate of CD4+ cell depletion and progression to AIDS. Ann Intern Med 118:681–688

    CAS  PubMed  Google Scholar 

  • Korber BT, Farber RM, Wolpert DH, Lapedes AS (1993) Covariation of mutations in the V3 loop of human immunodeficiency virus type 1 envelope protein: an information theoretic analysis. Proc Natl Acad Sci U S A 90:7176–7180

    CAS  PubMed  Google Scholar 

  • Koup RA, Safrit JT, Cao Y, Andrews CA, McLeod G, Borkowsky W, Farthing C, Ho DD (1994) Temporal association of cellular immune responses with the initial control of viremia in primary human immunodeficiency virus type 1 syndrome. J Virol 68:4650–4655

    CAS  PubMed  Google Scholar 

  • Learn GH, Muthui D, Brodie SJ, Zhu T, Diem K, Mullins JI, Corey L (2002) Virus population homogenization following acute human immunodeficiency virus type 1 infection. J Virol 76:11953–11959

    Article  CAS  PubMed  Google Scholar 

  • Leigh-Brown AJ (1997) Analysis of HIV-1 env gene sequences reveals evidence for a low effective number in the viral population. Proc Natl Acad Sci U S A 94:1862–1865

    Google Scholar 

  • Leslie AJ, Pfafferott KJ, Chetty P, Draenert R, Addo MM, Feeney M, Tang Y, Holmes EC, Allen T, Prado JG, Altfeld M, Brander C, Dixon C, Ramduth D, Jeena P, Thomas SA, John AS, Roach TA, Kupfer B, Luzzi G, Edwards A, Taylor G, Lyall H, Tudor-Williams G, Novelli V, Martinez-Picado J, Kiepiela P, Walker BD, Goulder PJ (2004) HIV evolution: CTL escape mutation and reversion after transmission. Nat Med 10:282–289

    Article  CAS  PubMed  Google Scholar 

  • Liu S-L, Mittler JE, Nickel DC, Mulvania TM, Shriner D, Rodrigo AG, Kosloff B, He X, Corey L, Mullins JI (2002) Selection for human immunodeficiency virus type 1 recombinants in a patient with rapid progression to AIDS. J Virol 76:10674–10684

    CAS  PubMed  Google Scholar 

  • Long EM, Martin HL Jr, Kreiss JK, Rainwater SM, Lavreys L, Jackson DJ, Rakwar J, Mandaliya K, Overbaugh J (2000) Gender differences in HIV-1 diversity at time of infection. Nat Med 6:71–75

    CAS  PubMed  Google Scholar 

  • Malaspina A, Moir S, Nickle DC, Donoghue ET, Ogwaro KM, Ehler LA, Liu S, Mican JA, Dybul M, Chun TW, Mullins JI, Fauci AS (2002) Human immunodeficiency virus type 1 bound to B cells: relationship to virus replicating in CD4(+) T cells and circulating in plasma. J Virol 76:8855–8863

    Article  CAS  PubMed  Google Scholar 

  • Mallon PW, Carr A, Cooper DA (2002) HIV-associated lipodystrophy: description, pathogenesis, and molecular pathways. Curr Diab Rep 2:116–124

    PubMed  Google Scholar 

  • Margolick JB, Donnenberg AD, Munoz A (1994) T lymphocyte homeostasis after HIV seroconversion. J Acquir Immune Defic Syndr 7:415–416

    CAS  PubMed  Google Scholar 

  • Margolick JB, Munoz A, Donnenberg AD et al (1995) Failure of T-cell homeostasis preceding AIDS in HIV-1 infection. Nat Med 1:674–680

    Article  CAS  PubMed  Google Scholar 

  • Mellors JW, Munoz A, Giorgi JV, Margolick JB, Tassoni CJ, Gupta P, Kingsley LA, Todd JA, Saah AJ, Detels R, Phair JP, Rinaldo CR Jr (1997) Plasma viral load and CD4+ lymphocytes as prognostic markers of HIV-1 infection. Ann Intern Med 126:946–954

    CAS  PubMed  Google Scholar 

  • Menzo S, Monachetti A, Balotta C, Corvasce S, Rusconi S, Paolucci S, Baldanti F, Bagnarelli P, Clementi M (2003) Processivity and drug-dependence of HIV-1 protease: determinants of viral fitness in variants resistant to protease inhibitors. Aids 17:663–671

    Article  CAS  PubMed  Google Scholar 

  • Michael NL, Chang G, Louie LG, Mascola JR, Dondero D, Birx DL, Sheppard HW (1997) The role of viral phenotype and CCR-5 gene defects in HIV-1 transmission and disease progression. Nat Med 3:338–340

    CAS  PubMed  Google Scholar 

  • Milich L, Margolin B, Swanstrom R (1993) V3 loop of the human immunodeficiency virus type 1 Env protein: interpreting sequence variability. J Virol 67:5623–5634

    CAS  PubMed  Google Scholar 

  • Miller V (2001) Structured treatment interruptions in antiretroviral management of HIV-1. Curr Opin Infect Dis 14:29–37

    PubMed  Google Scholar 

  • Moore CB, John M, James IR, Christiansen FT, Witt CS, Mallal SA (2002) Evidence of HIV-1 adaptation to HLA-restricted immune responses at a population level. Science 296:1439–1443

    Article  CAS  PubMed  Google Scholar 

  • Mullins JI (1997) Curtailing the AIDS pandemic (letter). Science 276:1955–1957

    Article  CAS  PubMed  Google Scholar 

  • Mullins JI, Hoover EA, Quackenbush SL, Donahue PR (1991) Disease progression and viral genome variants in experimental feline leukemia virus-induced immunodeficiency syndrome (published erratum appears in J Acquir Immune Defic Syndr 1991;4:925). J Acquir Immune Defic Syndr 4:547–557

    CAS  PubMed  Google Scholar 

  • Mullins JI, Nickle DC, Heath L, Rodrigo AG, Learn GH (2004) Immunogen sequence: the fourth tier of AIDS vaccine design. Expert Rev Vaccines 3[Suppl 1]: S151–S159

    CAS  PubMed  Google Scholar 

  • Muñoz A, Sabin CA, Phillips AN (1997) The incubation period of AIDS. AIDS 11:S69–S76

    PubMed  Google Scholar 

  • Nickle DC, Jensen MA, Shriner D, Brodie SJ, Frenkel LM, Mittler JE, Mullins JI (2003a) Evolutionary indicators of human immunodeficiency virus type 1 reservoirs and compartments. J Virol 77:5540–5546

    Article  CAS  PubMed  Google Scholar 

  • Nickle DC, Shriner D, Mittler JE, Frenkel LM, Mullins JI (2003b) Importance and detection of virus reservoirs and compartments of HIV infection. Curr Opin Microbiol 6:410–416

    Article  PubMed  Google Scholar 

  • Nijhuis M, Deeks S, Boucher C (2001) Implications of antiretroviral resistance on viral fitness. Curr Opin Infect Dis 14:23–28

    CAS  PubMed  Google Scholar 

  • O’Brien SJ, Nelson GW (2004) Human genes that limit AIDS. Nat Genet 36:565–574

    CAS  PubMed  Google Scholar 

  • O’Brien TR, Winkler C, Dean M, Nelson JA, Carrington M, Michael NL, White GC 2nd (1997) HIV-1 infection in a man homozygous for CCR5 delta 32. Lancet 349:1219

    CAS  PubMed  Google Scholar 

  • Overbaugh J, Donahue PR, Quackenbush SL, Hoover EA, Mullins JI (1988) Molecular cloning of a feline leukemia virus that induces fatal immunodeficiency disease in cats. Science 239:906–910

    CAS  PubMed  Google Scholar 

  • Oxenius A, Hirschel B (2003) Structured treatment interruptions in HIV infection: benefit or disappointment? Expert Rev Anti Infect Ther 1:129–139

    Article  PubMed  Google Scholar 

  • Palella FJ Jr, Delaney KM, Moorman AC, Loveless MO, Fuhrer J, Satten GA, Aschman DJ, Holmberg SD (1998) Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators. N Engl J Med 338:853–860

    Article  PubMed  Google Scholar 

  • Perelson AS, Neumann AU, Markowitz M, Leonard JM, Ho DD (1996) HIV-1 dynamics in vivo: virion clearance rate, infected cell life-span, and viral generation time. Science 271:1582–1586

    CAS  PubMed  Google Scholar 

  • Quinones-Mateu ME, Arts EJ (2002) HIV-1 fitness: implications for drug resistance, disease progression, and global epidemic evolution. In: Kuiken C, Foley B, Hahn B, Marx P, McCutchan F, Mellors J, Wolinsky S, Korber B (eds) HIV Sequence Compendium 2001. Theoretical Biology and Biophysics Group, Los Alamos National Laboratory, Los Alamos, NM, pp 134–170

    Google Scholar 

  • Quinones-Mateu ME, Ball SC, Marozsan AJ, Torre VS, Albright JL, Vanham G, van Der Groen G, Colebunders RL, Arts EJ (2000) A dual infection/competition assay shows a correlation between ex vivo human immunodeficiency virus type 1 fitness and disease progression. J Virol 74:9222–9233

    Article  CAS  PubMed  Google Scholar 

  • Resch W, Hoffman N, Swanstrom R (2001) Improved success of phenotype prediction of the human immunodeficiency virus type 1 from envelope variable loop 3 sequence using neural networks. Virology 288:51–62

    Article  CAS  PubMed  Google Scholar 

  • Rhodes T, Wargo H, Hu WS (2003) High rates of human immunodeficiency virus type 1 recombination: near-random segregation of markers one kilobase apart in one round of viral replication. J Virol 77:11193–11200

    Article  CAS  PubMed  Google Scholar 

  • Rodrigo AG (1997) Dynamics of syncytium-inducing and non-syncytium-inducing type 1 human immunodeficiency viruses during primary infection. AIDS Res Human Retrovir 13:1447–1451

    CAS  Google Scholar 

  • Rosenberg ES, Altfeld M, Poon SH, Phillips MN, Wilkes BM, Eldridge RL, Robbins GK, D’Aquila RT, Goulder PJ, Walker BD (2000) Immune control of HIV-1 after early treatment of acute infection. Nature 407:523–526

    CAS  PubMed  Google Scholar 

  • Ruiz L, Martinez-Picado J, Romeu J, Paredes R, Zayat MK, Marfil S, Negredo E, Sirera G, Tural C, Clotet B (2000) Structured treatment interruption in chronically HIV-1 infected patients after long-term viral suppression. Aids 14:397–403

    CAS  PubMed  Google Scholar 

  • Sagar M, Lavreys L, Baeten JM, Richardson BA, Mandaliya K, Chohan BH, Kreiss JK, Overbaugh J (2003) Infection with multiple human immunodeficiency virus type 1 variants is associated with faster disease progression. J Virol 77:12921–12926

    Article  CAS  PubMed  Google Scholar 

  • Schacker TW, Hughes JP, Shea T, Coombs RW, Corey L (1998) Biological and virologic characteristics of primary HIV infection. Ann Intern Med 128:613–620

    CAS  PubMed  Google Scholar 

  • Schrager LK, D’Souza MP (1998) Cellular and anatomical reservoirs of HIV-1 in patients receiving potent antiretroviral combination therapy. JAMA 280:67–71

    Article  CAS  PubMed  Google Scholar 

  • Shankarappa R, Margolick JB, Gange SJ, Rodrigo AG, Upchurch D, Farzadegan H, Gupta P, Rinaldo CR, Learn GH, He X, Huang XL, Mullins JI (1999) Consistent viral evolutionary changes associated with the progression of human immunodeficiency virus type 1 infection. J Virol 73:10489–10502

    CAS  PubMed  Google Scholar 

  • Shpaer EG, Delwart EL, Kuiken CL, Goudsmit J, Bachmann MH, Mullins JI (1994) Conserved V3 loop sequences and transmission of human immunodeficiency virus type 1. AIDS Res Hum Retroviruses 10:1679–1684

    CAS  PubMed  Google Scholar 

  • Shriner D, Rodrigo AG, Nickle DC, Mullins JI (2004a) Pervasive genomic recombination of HIV-1 in vivo. Genetics 167:1573–1583

    Article  CAS  PubMed  Google Scholar 

  • Shriner D, Shankarappa R, Jensen MA, Nickle DC, Mittler JE, Margolick JB, Mullins JI (2004b) Influence of random genetic drift on HIV-1 env evolution during chronic infection. Genetics 166:1155–1164

    Article  CAS  PubMed  Google Scholar 

  • Siliciano JD, Kajdas J, Finzi D, Quinn TC, Chadwick K, Margolick JB, Kovacs C, Gange SJ, Siliciano RF (2003) Long-term follow-up studies confirm the stability of the latent reservoir for HIV-1 in resting CD4(+) T cells. Nat Med 9:727–728

    Article  CAS  PubMed  Google Scholar 

  • Stoddart CA, Geleziunas R, Ferrell S, Linquist-Stepps V, Moreno ME, Bare C, Xu W, Yonemoto W, Bresnahan PA, McCune JM, Greene WC (2003) Human immunodeficiency virus type 1 nef-mediated downregulation of CD4 correlates with nef enhancement of viral pathogenesis. J Virol 77:2124–2133

    Article  CAS  PubMed  Google Scholar 

  • Tanaka M, Ueno T, Nakahara T, Sasaki K, Ishimoto A, Sakai H (2003) Downregulation of CD4 is required for maintenance of viral infectivity of HIV-1. Virology 311:316–325

    Article  CAS  PubMed  Google Scholar 

  • Tang J, Tang S, Lobashevsky E, Zulu I, Aldrovandi G, Allen S, Kaslow RA (2004) HLA allele sharing and HIV type 1 viremia in seroconverting Zambians with known transmitting partners. AIDS Res Hum Retroviruses 20:19–25

    Article  CAS  PubMed  Google Scholar 

  • Tersmette M, de Goede REY, Al BJM, Winkel IN, Gruters RA, Cuypers HT, Huisman HG, Miedema F (1988) Differential syncytium-inducing capacity of HIV isolates: frequent detection of syncytium-inducing isolates in patients with AIDS and AIDS-related complex. J Virol 62:2026–2032

    CAS  PubMed  Google Scholar 

  • Tersmette M, Gruters RA, de Wolf F, de Goede RE, Lange JM, Schellekens PT, Goudsmit J, Huisman HG, Miedema F (1989) Evidence for a role of virulent human immunodeficiency virus (HIV) variants in the pathogenesis of acquired immunodeficiency syndrome: studies on sequential HIV isolates. J Virol 63:2118–2125

    CAS  PubMed  Google Scholar 

  • Theodorou I, Meyer L, Magierowska M, Katlama C, Rouzioux C (1997) HIV-1 infection in an individual homozygous for CCR5 delta 32. Seroco Study Group. Lancet 349:1219–1220

    Article  CAS  PubMed  Google Scholar 

  • Trachtenberg E, Korber B, Sollars C, Kepler TB, Hraber PT, Hayes E, Funkhouser R, Fugate M, Theiler J, Hsu YS, Kunstman K, Wu S, Phair J, Erlich H, Wolinsky S (2003) Advantage of rare HLA supertype in HIV disease progression. Nat Med 9:928–935

    Article  CAS  PubMed  Google Scholar 

  • Tremblay CL, Hicks JL, Sutton L, Giguel F, Flynn T, Johnston M, Sax PE, Walker BD, Hirsch MS, Rosenberg ES, D’Aquila RT (2003) Antiretroviral resistance associated with supervised treatment interruptions in treated acute HIV infection. Aids 17:1086–1089

    Article  PubMed  Google Scholar 

  • Van’ t Wout AB, Kootstra NA, Mulder-Kampinga GA, Albrecht-van Lent N, Scherpbier HJ, Veenstra J, Boer K, Coutinho RA, Miedema F, Schuitemaker H (1994) Macrophage-tropic variants initiate HIV-1 infection after sexual, parenteral, and vertical transmission. J Clin Invest 94:2060–2067

    Google Scholar 

  • Van Rij RP, Blaak H, Visser JA, Brouwer M, Rientsma R, Broersen S, de Roda Husman AM, Schuitemaker H (2000) Differential coreceptor expression allows for independent evolution of non-syncytium-inducing and syncytium-inducing HIV-1. J Clin Invest 106:1039–1052

    PubMed  Google Scholar 

  • Wei X, Ghosh SK, Taylor ME, Johnson VA, Emini EA, Deutsch P, Lifson JD, Bonhoeffer S, Nowak MA, Hahn BH, Saag MS, Shaw GM (1995) Viral dynamics in human immunodeficiency virus type 1 infection. Nature 373:117–122

    Article  CAS  PubMed  Google Scholar 

  • Wein LM, D’Amato RM, Perelson AS (1997) Mathematical analysis of antiviral therapy aimed at HIV-1 eradication or maintenance of low viral loads. J Theor Biol 192:81–98

    Google Scholar 

  • Yang OO, Daar ES, Jamieson BD, Balamurugan A, Smith DM, Pitt JA, Petropoulos CJ, Richman DD, Little SJ, Brown AJ (2005) Human immunodeficiency virus type 1 clade B superinfection: evidence for differential immune containment of distinct clade B strains. J Virol 79:860–868

    CAS  PubMed  Google Scholar 

  • Yusim K, Kesmir C, Gaschen B, Addo MM, Altfeld M, Brunak S, Chigaev A, Detours V, Korber BT (2002) Clustering patterns of cytotoxic T-lymphocyte epitopes in human immunodeficiency virus type 1 (HIV-1) proteins reveal imprints of immune evasion on HIV-1 global variation. J Virol 76:8757–8768

    Article  CAS  PubMed  Google Scholar 

  • Zhang LQ, MacKenzie P, Cleland A, Holmes EC, Leigh Brown AJ, Simmonds P (1993) Selection for specific sequences in the external envelope protein of HIV-1 upon primary infection. J Virol 67:3345–3356

    CAS  PubMed  Google Scholar 

  • Zhu T, Mo H, Wang N, Nam DS, Cao Y, Koup RA, Ho DD (1993) Genotypic and phenotypic characterization of HIV-1 in patients with primary infection. Science 261:1179–1181

    CAS  PubMed  Google Scholar 

  • Zhu T, Corey L, Akridge R, Change Y, Feng F, Kim J, Alef C, McElroy A, Mullins J, McElrath J (1999) Evidence for HIV-1 latent infection in exposed seronegative individuals. 6th Conference on Retroviruses and Opportunistic Infections, Chicago

    Google Scholar 

  • Zhu T, Brodie S, Mullins JI, Corey L (2000) Reservoirs of viral persistence after HAART therapy of primary HIV. International meeting of the Institute of Human Virology, Baltimore

    Google Scholar 

  • Zhu T, Muthui D, Holte S, Nickle D, Feng F, Brodie S, Hwangbo Y, Mullins JI, Corey L (2002) Evidence for human immunodeficiency virus type 1 replication in vivo in CD14(+) monocytes and its potential role as a source of virus in patients on highly active antiretroviral therapy. J Virol 76:707–716

    CAS  PubMed  Google Scholar 

  • Zhu T, Corey L, Hwangbo Y, Lee JM, Learn GH, Mullins JI, McElrath MJ (2003) Persistence of extraordinarily low levels of genetic homogeneous human immunodeficiency virus type 1 in exposed seronegative individuals. J Virol 77:6108–6116

    CAS  PubMed  Google Scholar 

  • Zhu T, Hu S-L, Feng F, Polacino P, Liu H, Hwangbo Y, Learn GH, Mullins JI, Corey L (2004) Persistence of low levels of simian immunodeficiency virus in macaques that were transiently viremic by conventional testing. Virology 323:208–219

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Departments of Microbiology, University of Washington School of Medicine, Seattle, WA, 98195-8070, USA

    J. I. Mullins & M. A. Jensen

Authors
  1. J. I. Mullins
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. M. A. Jensen
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Centro de BiologÍa Molecular “Servero Ochoa” (CSIC-UAM), Universidad Autónoma de Madrid, 28049, Cantoblanco, Madrid, Spain

    Esteban Domingo

Rights and permissions

Reprints and permissions

Copyright information

© 2006 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Mullins, J.I., Jensen, M.A. (2006). Evolutionary Dynamics of HIV-1 and the Control of AIDS. In: Domingo, E. (eds) Quasispecies: Concept and Implications for Virology. Current Topics in Microbiology and Immunology, vol 299. Springer, Berlin, Heidelberg. https://doi.org/10.1007/3-540-26397-7_6

Download citation

Publish with us

Policies and ethics

Search

Navigation